DKSC (Dakshidin) EV-to-EBIT: (As of Aug. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Dakshidin EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Dakshidin's Enterprise Value is $0.00 Mil. Dakshidin does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Sep. 2023. Therefore, GuruFocus does not calculate Dakshidin's EV-to-EBIT at this moment.

The historical rank and industry rank for Dakshidin's EV-to-EBIT or its related term are showing as below:

DKSC's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 15.855
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Dakshidin's Enterprise Value for the quarter that ended in Sep. 2023 was $1.44 Mil. Dakshidin does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Sep. 2023. Therefore, GuruFocus does not calculate Dakshidin's Earnings Yield (Joel Greenblatt) % at this moment.

Dakshidin  (OTCPK:DKSC) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Dakshidin's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 ) =EBIT / Enterprise Value (Q: Sep. 2023 )
=/1.43638
= %

Dakshidin EV-to-EBIT Related Terms

Dakshidin EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Dakshidin's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dakshidin EV-to-EBIT Chart

Dakshidin Annual Data
Trend
EV-to-EBIT

Dakshidin Quarterly Data
Mar19 Mar20 Sep22 Sep23
EV-to-EBIT 0.00 0.00 0.00 0.00

DKSC vs ECEZ, AFBG, CESX: EV-to-EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Dakshidin's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dakshidin EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dakshidin's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Dakshidin's EV-to-EBIT falls into.


Dakshidin EV-to-EBIT Calculation

Dakshidin's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/
=

Dakshidin Business Description

Address 508 Locust Street, Lockport, NY, USA, 14094
Dakshidin Corp is a Cannabis-based medical product company. The company operates through its online e-commerce store laughingfrogs.com. The company is composed of four synergistic entities: Laughing Frogs, an online sales portal for the company's CBD products; Laughing Frogs Nutraceutical the online sales portal for all non-CBD hemp oil products and its proprietary nutraceutical products, company's new PPE division and Runnymede Farms, a company that is focused on the cultivation of specifically grown Hemp plants. through its growing operations and Joint Ventures with established growers.